Novel Mechanisms of Acute Lung Injury: Tidal Flooding, Epithelial Glycocalyx Shedding, and Platelet-Derived Extracellular Vesicles

Needs Statement

Physicians, residents, fellows, and other healthcare professionals involved in research or desiring to pursue research projects need to be regularly updated with the recent advances in the development of research (basic, clinical, quality improvement, and health services) strategies to increase knowledge and to implement them in their departments and institutions to enhance research and health care outcomes.

Educational Objectives

At the conclusion of the sessions, the participants should be able to:

• Identify research projects, initiatives, and priorities at the Michael E. DeBakey VA Medical Center aimed at improving healthcare for veterans.
• Apply expertise in various areas of research into future or existing projects, highlighting the role or physician-scientists.
• Discuss recent advances in the development of research (basic, clinical, and health services) modalities.
• Implement strategies to conduct basic science, clinical translational, and quality improvement research such as preparation of appropriate and effective individual and collaborative federal research grant applications and institutional review board protocols.

Target Audience

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.